Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 6
2006 11
2007 7
2008 5
2009 8
2010 3
2011 4
2012 2
2013 6
2014 6
2015 8
2016 5
2017 10
2018 12
2019 8
2020 13
2021 16
2022 18
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Stroke: Molecular Mechanisms and Therapies.
Vemuganti R. Vemuganti R. Neuromolecular Med. 2019 Dec;21(4):323-324. doi: 10.1007/s12017-019-08580-4. Neuromolecular Med. 2019. PMID: 31745713 No abstract available.
Immunomodulatory role of glycoRNAs in the brain.
Chokkalla AK, Jeong S, Subramanian S, Vemuganti R. Chokkalla AK, et al. Among authors: vemuganti r. J Cereb Blood Flow Metab. 2023 Apr;43(4):499-504. doi: 10.1177/0271678X231151995. Epub 2023 Jan 16. J Cereb Blood Flow Metab. 2023. PMID: 36644904 Free PMC article. Review.
Long noncoding RNAs and CNS disorders.
Yin KJ, Vemuganti R. Yin KJ, et al. Among authors: vemuganti r. Neurochem Int. 2021 Nov;150:105176. doi: 10.1016/j.neuint.2021.105176. Epub 2021 Sep 1. Neurochem Int. 2021. PMID: 34481038 No abstract available.
Oxidative stress in chronic and acute CNS insults.
Vemuganti R, Shah Z. Vemuganti R, et al. Neurochem Int. 2022 Feb;153:105274. doi: 10.1016/j.neuint.2021.105274. Epub 2021 Dec 28. Neurochem Int. 2022. PMID: 34971748 No abstract available.
Epigenetic mechanisms and potential therapeutic targets in stroke.
Morris-Blanco KC, Chokkalla AK, Arruri V, Jeong S, Probelsky SM, Vemuganti R. Morris-Blanco KC, et al. Among authors: vemuganti r. J Cereb Blood Flow Metab. 2022 Nov;42(11):2000-2016. doi: 10.1177/0271678X221116192. Epub 2022 Jul 19. J Cereb Blood Flow Metab. 2022. PMID: 35854641 Free PMC article. Review.
Non-pharmacological interventions for traumatic brain injury.
Davis CK, Arruri V, Joshi P, Vemuganti R. Davis CK, et al. Among authors: vemuganti r. J Cereb Blood Flow Metab. 2024 Feb 22:271678X241234770. doi: 10.1177/0271678X241234770. Online ahead of print. J Cereb Blood Flow Metab. 2024. PMID: 38388365 Review.
DNA damage and repair following traumatic brain injury.
Davis CK, Vemuganti R. Davis CK, et al. Among authors: vemuganti r. Neurobiol Dis. 2021 Jan;147:105143. doi: 10.1016/j.nbd.2020.105143. Epub 2020 Oct 28. Neurobiol Dis. 2021. PMID: 33127471 Free article. Review.
MMP-12, a Promising Therapeutic Target for Neurological Diseases.
Chelluboina B, Nalamolu KR, Klopfenstein JD, Pinson DM, Wang DZ, Vemuganti R, Veeravalli KK. Chelluboina B, et al. Among authors: vemuganti r. Mol Neurobiol. 2018 Feb;55(2):1405-1409. doi: 10.1007/s12035-017-0418-5. Epub 2017 Feb 2. Mol Neurobiol. 2018. PMID: 28155200 Review.
Antioxidant therapies in traumatic brain injury.
Davis CK, Vemuganti R. Davis CK, et al. Among authors: vemuganti r. Neurochem Int. 2022 Jan;152:105255. doi: 10.1016/j.neuint.2021.105255. Epub 2021 Dec 13. Neurochem Int. 2022. PMID: 34915062
140 results